Browse Categories

Publications by authors named "Peter Sidaway"

  • Page 1 of 16
Women with clinically node negative breast cancer can safely avoid axillary surgery.
Peter Sidaway

Nat Rev Clin Oncol

January 2025

View Article and Find Full Text PDF
Adding blinatumomab to chemotherapy reduces recurrence risk in standard-risk paediatric B-ALL.
Peter Sidaway

Nat Rev Clin Oncol

December 2024

View Article and Find Full Text PDF
Ipilimumab plus nivolumab efficacious in patients with dMMR/MSI-H disease.
Peter Sidaway

Nat Rev Clin Oncol

December 2024

View Article and Find Full Text PDF
HIPEC is effective in patients undergoing cytoreduction for recurrent ovarian cancer.
Peter Sidaway

Nat Rev Clin Oncol

January 2025

View Article and Find Full Text PDF
MRI-based stratification reduces the risk of overdiagnosis of prostate cancer.
Peter Sidaway

Nat Rev Clin Oncol

December 2024

View Article and Find Full Text PDF
A new standard of care for leiomyosarcoma.
Peter Sidaway

Nat Rev Clin Oncol

November 2024

View Article and Find Full Text PDF
Tisotumab vedotin effective in recurrent cervical cancer.
Peter Sidaway

Nat Rev Clin Oncol

October 2024

View Article and Find Full Text PDF
Addition of sintilimab to standard therapy improves event-free survival.
Peter Sidaway

Nat Rev Clin Oncol

September 2024

View Article and Find Full Text PDF
Osimertinib efficacious as maintenance therapy in patients with stage III NSCLC.
Peter Sidaway

Nat Rev Clin Oncol

August 2024

View Article and Find Full Text PDF
Neoadjuvant ipilimumab-nivolumab superior to adjuvant nivolumab.
Peter Sidaway

Nat Rev Clin Oncol

August 2024

View Article and Find Full Text PDF
Ponatinib superior to imatinib in Ph ALL.
Peter Sidaway

Nat Rev Clin Oncol

July 2024

View Article and Find Full Text PDF
Laparoscopic hemihepatectomy is safe and effective.
Peter Sidaway

Nat Rev Clin Oncol

July 2024

View Article and Find Full Text PDF
Adjuvant pembrolizumab improves overall survival in patients with RCC.
Peter Sidaway

Nat Rev Clin Oncol

July 2024

View Article and Find Full Text PDF
Afami-cel provides a novel treatment option for rare sarcoma subtypes.
Peter Sidaway

Nat Rev Clin Oncol

June 2024

View Article and Find Full Text PDF
Pembrolizumab plus chemoradiotherapy effective in locally advanced cervical cancer.
Peter Sidaway

Nat Rev Clin Oncol

June 2024

View Article and Find Full Text PDF
A new standard of care for advanced-stage urothelial carcinoma.
Peter Sidaway

Nat Rev Clin Oncol

May 2024

View Article and Find Full Text PDF
Pegargiminase improves outcomes in nonepithelioid MPM.
Peter Sidaway

Nat Rev Clin Oncol

May 2024

View Article and Find Full Text PDF
KN046 shows tolerability and activity in TNBC.
Peter Sidaway

Nat Rev Clin Oncol

April 2024

View Article and Find Full Text PDF
Adjuvant sintilimab effective in high-risk HCC.
Peter Sidaway

Nat Rev Clin Oncol

March 2024

View Article and Find Full Text PDF
Repotrectinib effective in ROS1-fusion-positive NSCLC.
Peter Sidaway

Nat Rev Clin Oncol

March 2024

View Article and Find Full Text PDF
Mirvetuximab soravtansine superior to chemotherapy in platinum-resistant epithelial ovarian cancer.
Peter Sidaway

Nat Rev Clin Oncol

February 2024

View Article and Find Full Text PDF
Tovorafenib effective against low-grade gliomas harbouring BRAF fusions.
Peter Sidaway

Nat Rev Clin Oncol

February 2024

View Article and Find Full Text PDF
From ESMO 2023: advances in lung cancer.
Peter Sidaway

Nat Rev Clin Oncol

January 2024

View Article and Find Full Text PDF
Patritumab deruxtecan shows activity in EGFR-mutant NSCLC.
Peter Sidaway

Nat Rev Clin Oncol

December 2023

View Article and Find Full Text PDF
Sacituzumab govitecan improves OS in heavily pretreated patients.
Peter Sidaway

Nat Rev Clin Oncol

November 2023

View Article and Find Full Text PDF
Privacy Policy Site Map

© LitMetric 2025. All rights reserved.